Fagan AM - Search Results

1

Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's disease.

Phillips B, Western D, Wang L, Timsina J, Sun Y, Gorijala P, Yang C, Do A, Nykänen NP, Alvarez I, Aguilar M, Pastor P, Morris JC, Schindler SE, Fagan AM, Puerta R, García-González P, de Rojas I, Marquié M, Boada M, Ruiz A, Perlmutter JS; Dominantly Inherited Alzheimer Network (DIAN) Consortia; Ibanez L, Perrin RJ, Sung YJ, Cruchaga C. Phillips B, et al. Among authors: fagan am. NPJ Parkinsons Dis. 2023 Jul 8;9(1):107. doi: 10.1038/s41531-023-00555-4. NPJ Parkinsons Dis. 2023. PMID: 37422510 Free PMC article.

2

Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia.

Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM. Han X, et al. Among authors: fagan am. Ann Neurol. 2003 Jul;54(1):115-9. doi: 10.1002/ana.10618. Ann Neurol. 2003. PMID: 12838527

3

The search for antecedent biomarkers of Alzheimer's disease.

Fagan AM, Csernansky CA, Morris JC, Holtzman DM. Fagan AM, et al. J Alzheimers Dis. 2005 Mar;8(4):347-58. doi: 10.3233/jad-2005-8404. J Alzheimers Dis. 2005. PMID: 16556966 Review.

4

Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.

Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC. Csernansky JG, et al. Among authors: fagan am. Am J Psychiatry. 2006 Dec;163(12):2164-9. doi: 10.1176/ajp.2006.163.12.2164. Am J Psychiatry. 2006. PMID: 17151169 Free PMC article.

5

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Fagan AM, et al. Arch Neurol. 2007 Mar;64(3):343-9. doi: 10.1001/archneur.64.3.noc60123. Epub 2007 Jan 8. Arch Neurol. 2007. PMID: 17210801

6

Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM. Kauwe JS, et al. Among authors: fagan am. Ann Neurol. 2007 May;61(5):446-53. doi: 10.1002/ana.21099. Ann Neurol. 2007. PMID: 17366635

7

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.

Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Kauwe JS, et al. Among authors: fagan am. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8050-4. doi: 10.1073/pnas.0801227105. Epub 2008 Jun 9. Proc Natl Acad Sci U S A. 2008. PMID: 18541914 Free PMC article.

8

Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM. Kauwe JS, et al. Among authors: fagan am. Neurogenetics. 2009 Feb;10(1):13-7. doi: 10.1007/s10048-008-0150-4. Epub 2008 Sep 24. Neurogenetics. 2009. PMID: 18813964 Free PMC article.

9

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, Holtzman DM. Fagan AM, et al. Ann Neurol. 2009 Feb;65(2):176-83. doi: 10.1002/ana.21559. Ann Neurol. 2009. PMID: 19260027 Free PMC article.

10

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.

Snider BJ, Fagan AM, Roe C, Shah AR, Grant EA, Xiong C, Morris JC, Holtzman DM. Snider BJ, et al. Among authors: fagan am. Arch Neurol. 2009 May;66(5):638-45. doi: 10.1001/archneurol.2009.55. Arch Neurol. 2009. PMID: 19433664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters